Drug intelligence / Profile preview

morroniside

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal (experimental)
01

Overview

**Morroniside** is a naturally occurring iridoid glycoside and the major bioactive component of *Cornus officinalis* (Corni Fructus, Shanzhuyu), a traditional Chinese medicinal herb. It possesses diverse biological activities including anti-inflammatory, neuroprotective, antinociceptive, cardioprotective, hepatoprotective, and antioxidative properties, as well as effects on bone and kidney health. Mechanistically, morroniside inhibits canonical and non-canonical NF-κB signaling, suppresses pro-inflammatory cytokines (such as TNFα, IL6, IL-1β), downregulates protein degradation pathways (including the myostatin/Smad, ubiquitin-proteasome, and autophagy-lysosome systems), and promotes protein synthesis (mainly IGF-1/PI3K/Akt pathway). It is under investigation primarily for its efficacy in inflammatory skeletal muscle atrophy, osteoarthritis, osteoporosis, and other conditions associated with inflammation and degeneration

Other names
molosideMorronisidb-MorronisideMorroniside-RMMorroniside Impurity 28-(β-D-Glucopyranosyloxy)-4,4a,8,8a-tetrahydro-3-hydroxy-1-methyl-1H,3H-pyrano[3,4-c]pyran-5-carboxylic acid methyl ester(1S,3R,4aS,8S,8aS)-8-(beta-D-Glucopyranosyloxy)-4,4a,8,8a-tetrahydro-3-hydroxy-1-methyl-1H,3H-pyrano[3,4-c]pyran-5-carboxylic acid methyl ester1H,3H-Pyrano[3,4-c]pyran-5-carboxylicacid, 8-(b-D-glucopyranosyloxy)-4,4a,8,8a-tetrahydro-3-hydroxy-1-methyl-,methyl esterCAS 25406-64-8CAS25406-64-8CAS-25406-64-8CHEBI:80852
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)FOXO3 (Forkhead box protein O3)GLP1R (GLP-1R)IGF-1R (Insulin-like growth factor 1 receptor)GDF8 (Myostatin)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on morroniside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morroniside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call